Highlights from ACP Internist and
ACP Internist Weekly (formerly ACP Observer) May/July 2009
- Urine protein predicts clot risk
Patients with microalbuminuria are at higher than average risk for venous thromboembolism (VTE), a new community-based prospective study in the Netherlands found.
- Stroke risk higher for Hodgkin's lymphoma survivors
Patients who have received radiation therapy as a treatment for Hodgkin's lymphoma have a substantially higher than average stroke risk, according to a new study.
- Experts recommend using A1c to diagnose diabetes
An international committee of experts has called for the A1c assay to become the recommended method for diagnosing diabetes.
- Longer androgen suppression boosts prostate cancer survival
Three years of androgen suppression after radiotherapy to treat locally advanced prostate cancer provides modestly better survival than six months of the hormone regimen, a European study concluded.
- Statins after first stroke reduce recurrent attacks
Prescribing statins upon hospital discharge to patients after their first acute stroke lowers the 10-year recurrence risk and improves survival, researchers reported.
ACP Hospitalist Weekly April/July 2009
- Hospital medicine around the world
The field is catching on in several countries outside the U.S., Canada and Europe. Although the health care systems and situations may differ, supporters’ reasons for wanting hospital medicine to flourish there are often the same, and the barriers are often similar, as well.
- Combining GFR, albuminuria predicts progression to end-stage renal disease
Estimated glomerular filtration rate (eGFR) and urinary albumin may predict who will develop end-stage renal disease (ESRD) and allow physicians to intervene earlier, according to Norwegian researchers.
Internal Medicine Meeting Early Registration Discount
Register early for Internal Medicine Meeting 2015 in Boston, MA to lock in the lowest possible rate. Learn more or register now!
Are You Using ACP Smart Medicine®?
This online clinical decision support tool is a FREE benefit of ACP membership delivering point-of-care access to evidence-based recommendations. Includes more than 500 modules, images and reference tables. Start now or watch the video tour.